1. Home
  2. CING vs KFFB Comparison

CING vs KFFB Comparison

Compare CING & KFFB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CING
  • KFFB
  • Stock Information
  • Founded
  • CING 2012
  • KFFB 2005
  • Country
  • CING United States
  • KFFB United States
  • Employees
  • CING N/A
  • KFFB N/A
  • Industry
  • CING Biotechnology: Pharmaceutical Preparations
  • KFFB Savings Institutions
  • Sector
  • CING Health Care
  • KFFB Finance
  • Exchange
  • CING Nasdaq
  • KFFB Nasdaq
  • Market Cap
  • CING 22.0M
  • KFFB 25.9M
  • IPO Year
  • CING 2021
  • KFFB 2005
  • Fundamental
  • Price
  • CING $3.72
  • KFFB $3.40
  • Analyst Decision
  • CING Strong Buy
  • KFFB
  • Analyst Count
  • CING 4
  • KFFB 0
  • Target Price
  • CING $31.00
  • KFFB N/A
  • AVG Volume (30 Days)
  • CING 132.0K
  • KFFB 1.5K
  • Earning Date
  • CING 11-06-2025
  • KFFB 11-11-2025
  • Dividend Yield
  • CING N/A
  • KFFB N/A
  • EPS Growth
  • CING N/A
  • KFFB N/A
  • EPS
  • CING N/A
  • KFFB N/A
  • Revenue
  • CING N/A
  • KFFB $8,308,000.00
  • Revenue This Year
  • CING N/A
  • KFFB N/A
  • Revenue Next Year
  • CING N/A
  • KFFB N/A
  • P/E Ratio
  • CING N/A
  • KFFB N/A
  • Revenue Growth
  • CING N/A
  • KFFB 13.79
  • 52 Week Low
  • CING $3.02
  • KFFB $1.96
  • 52 Week High
  • CING $6.01
  • KFFB $3.97
  • Technical
  • Relative Strength Index (RSI)
  • CING 40.66
  • KFFB 53.79
  • Support Level
  • CING $3.62
  • KFFB $3.12
  • Resistance Level
  • CING $4.00
  • KFFB $3.97
  • Average True Range (ATR)
  • CING 0.20
  • KFFB 0.06
  • MACD
  • CING 0.01
  • KFFB 0.03
  • Stochastic Oscillator
  • CING 22.20
  • KFFB 38.04

About CING Cingulate Inc.

Cingulate Inc is a clinical-stage biopharmaceutical company utilizing its proprietary precision timed-release drug delivery platform to build and advance a pipeline of next-generation pharmaceutical products designed to improve the lives of patients suffering from frequently diagnosed conditions characterized by burdensome daily dosing regimens and suboptimal treatment outcomes. The company focuses on the treatment of Attention Deficit/Hyperactivity Disorder (ADHD) and anxiety, and identifying and evaluating additional therapeutic area to use PTR technology to develop future product candidates.

About KFFB Kentucky First Federal Bancorp

Kentucky First Federal Bancorp is a holding company. The company through its subsidiaries is engaged mainly in the business of accepting deposits from the general public and using such funds to originate loans secured by first mortgages on owner-occupied, residential real estate and other loans secured by real estate. Its primary products and services include Residential mortgage loans, Multi-family loans, Construction loans and types of deposits, etc. The company mainly operates in Perry, Franklin, Boyle and Garrard and surrounding counties in Kentucky, US.

Share on Social Networks: